Joshua T Myers
Papers
1
Total Citations
2
H-Index
1
About
Joshua T. Myers is a pioneering biomedical researcher whose work centers on innovative drug delivery systems, with a particular focus on oral biologics and robotic pill technology. His major contributions lie in demonstrating the feasibility of orally administering complex protein therapeutics, such as parathyroid hormone analogs, which traditionally require injection. In his landmark Phase 1 study, Myers and his team showed that an orally administered robotic pill could reliably and safely deliver teriparatide (hPTH[1-34]) with high bioavailability in healthy volunteers—a breakthrough that could transform the management of osteoporosis and other endocrine disorders. This work, published in 2023, has already garnered early citations, reflecting its significance in the field. As an employee and stock owner at Rani Therapeutics, Myers is at the forefront of translating this technology from bench to bedside. His research addresses a critical unmet need: improving patient compliance by replacing painful injections with a painless, oral alternative. For students and researchers, Myers exemplifies how interdisciplinary engineering and pharmacology can converge to solve real-world clinical challenges, making his profile a compelling case study in translational medicine.
Research Focus
Key Achievements
Top Papers
- 1